Related Experiment Video
Updated: Dec 17, 2025

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Can Anticoagulation Be Stopped After Ablation of Atrial Fibrillation?
Jackson J Liang1, David J Callans2
1Electrophysiology Service, Division of Cardiology, University of Michigan, Ann Arbor, MI, USA.
Insights
Discontinuing oral anticoagulation therapy (OAT) after atrial fibrillation (AF) catheter ablation is debated. Successful ablation may reduce stroke risk, potentially allowing OAT cessation in select AF patients with monitoring.
Area of Science:
- Cardiology
- Electrophysiology
- Neurology
Background:
- Atrial fibrillation (AF) increases stroke risk via cerebrovascular embolic events (CVEs).
- Oral anticoagulation therapy (OAT) prevents CVEs in AF patients.
- Catheter ablation is an effective AF treatment.
Purpose of the Study:
- To review the benefits and drawbacks of stopping OAT post-AF ablation.
- To analyze study data on OAT cessation after AF ablation.
- To summarize current expert consensus recommendations.
Main Methods:
- Review of existing literature and retrospective studies.
- Analysis of data on CVEs in AF patients undergoing ablation.
- Synthesis of Expert Consensus guidelines.
Main Results:
- Successful AF ablation may reduce CVE risk.
- Some studies suggest OAT can be safely discontinued in select patients post-ablation.
- Continued rhythm monitoring is advised if OAT is stopped.
Conclusions:
- Discontinuation of OAT after successful AF ablation is a complex decision.
- Patient selection and long-term monitoring are crucial for safe OAT cessation.
- Further research is needed to solidify guidelines on OAT management post-ablation.
Purpose Of Review:
This review discusses the pros and cons of discontinuing oral anticoagulation therapy (OAT) after catheter ablation of atrial fibrillation (AF), and data from relevant studies, and summarizes the most recent Expert Consensus recommendations on the topic.
Recent Findings:
Patients with AF are at risk of cerebrovascular embolic events (CVEs) including stroke and transient ischemic attacks. OAT can be effective in preventing CVEs, while catheter ablation is an effective treatment to eliminate AF. Whether OAT can be safely discontinued after successful AF ablation remains a controversial topic. Retrospective studies have suggested that successful AF ablation may mitigate the risk of CVE such that OAT may be discontinued in select patients after AF ablation. In certain patients with AF who undergo successful AF ablation, OAT might be able to be safely discontinued with continued long-term rhythm monitoring.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Hemodialysis I: Introduction
Cardiac Catheterization IV: Nursing Management

